SCICLONE PHARMACEUTICALS INC's ticker is SCLN and the CUSIP is 80862K104. A total of 95 filers reported holding SCICLONE PHARMACEUTICALS INC in Q2 2014. The put-call ratio across all filers is 59.40 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2016 | $3,624,000 | +160.3% | 329,495 | +117.5% | 0.01% | +200.0% |
Q4 2015 | $1,392,000 | -50.6% | 151,471 | -62.7% | 0.00% | -60.0% |
Q3 2015 | $2,815,000 | +66.7% | 405,556 | +135.9% | 0.01% | +66.7% |
Q2 2015 | $1,689,000 | -1.9% | 171,893 | -11.5% | 0.00% | 0.0% |
Q1 2015 | $1,721,000 | -54.6% | 194,128 | -55.1% | 0.00% | -57.1% |
Q4 2014 | $3,788,000 | +116.5% | 432,422 | +70.2% | 0.01% | +133.3% |
Q3 2014 | $1,750,000 | +246.5% | 254,034 | +142.0% | 0.00% | +200.0% |
Q2 2014 | $505,000 | +5.6% | 104,974 | 0.0% | 0.00% | 0.0% |
Q1 2014 | $478,000 | -9.0% | 104,974 | -4.8% | 0.00% | 0.0% |
Q4 2013 | $525,000 | -38.6% | 110,237 | -32.9% | 0.00% | -50.0% |
Q3 2013 | $855,000 | +809.6% | 164,363 | +766.6% | 0.00% | – |
Q2 2013 | $94,000 | – | 18,966 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Athos Capital Ltd | 284,200 | $3,126,000 | 1.80% |
Nine Chapters Capital Management LLC | 13,600 | $150,000 | 1.42% |
Stonepine Capital Management, LLC | 216,307 | $2,379,000 | 1.28% |
GLG Partners LP | 1,588,897 | $17,478,000 | 0.97% |
MENTA CAPITAL LLC | 431,996 | $4,752,000 | 0.56% |
Sapphire Star Partners LP | 24,834 | $273,000 | 0.34% |
Yakira Capital Management, Inc. | 85,500 | $941,000 | 0.28% |
TFS CAPITAL LLC | 55,104 | $606,000 | 0.24% |
BRANT POINT INVESTMENT MANAGEMENT LLC | 100,000 | $1,100,000 | 0.13% |
GABELLI & Co INVESTMENT ADVISERS, INC. | 102,261 | $1,125,000 | 0.12% |